Role of dietary potassium and salt substitution in the prevention and management of hypertension
- PMID: 39472546
- DOI: 10.1038/s41440-024-01862-w
Role of dietary potassium and salt substitution in the prevention and management of hypertension
Abstract
Cardiovascular diseases (CVD) continue to be the leading cause of deaths and disability worldwide and the major contributor is hypertension. Despite all the improvements in detecting hypertension together with technological advances and affordable, efficacious and relatively free of adverse effects anti-hypertensive agents, we continue to struggle to prevent the onset of hypertension and to control blood pressure (BP) to acceptable targets. The poor control of hypertension is commonly due to non-adherence to medications. Another reason is the failure to adopt diet and lifestyle changes. Reduction of dietary salt intake is important for lowering BP but the role of potassium intake is also important. Globally the intake of sodium is double that of the recommended 2 gm per day (equivalent to 5 gm of sodium chloride/salt) and half that of the daily recommended intake of potassium of 3500 mg/day, giving a sodium-to-potassium ratio of >1, when ideally it should be <1. Many studies have shown that a higher potassium intake is associated with lower BPs, particularly when coupled concurrently with a lower sodium intake giving a lower sodium to potassium ratio. Most hypertension guidelines, while recommending reduction of salt intake to a set target, do not specifically recommend a target for potassium intake nor potassium supplementation. Here we review the role of potassium and salt substitution with potassium in the management of hypertension. Hence, the focus of dietary changes to lower BP and improve BP control should not be on reduction of salt intake alone but more importantly should include an increase in potassium intake.
Keywords: Dietary potassium; Hypertension; Prevention; Salt substitution; Sodium to potassium ratio.
© 2024. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
Conflict of interest statement
Compliance with ethical standards. Conflict of interest: YCC has received Research grants from Pfizer and Omron, Speaker honorarium from Astra-Zeneca, Medtronic, MIMS, Omron, Xepa-Sol, Viatris, Duopharma and Unrestricted educational grants on behalf of HOPE-Asia Network from Viatris and on behalf of the Malaysian Society for World Action on Salt, Sugar and Health (MyWASSH) from Medtronic. FJH is an unpaid member of Action on Salt and World Action on Salt, Sugar and Health (WASSH). All other authors report no potential conflicts of interest in relation to this article.
References
-
- WHO. The Top 10 Causes of Death 2020 https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death .
-
- World Heart Federation Hypertension https://world-heart-federation.org/what-we-do/hypertension/ .
-
- Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347–60. - PubMed
-
- Chia Y-C, Buranakitjaroen P, Chen C-H, Divinagracia R, Hoshide S, Park S, et al. Current status of home blood pressure monitoring in Asia: Statement from the HOPE Asia Network. J Clin Hypertension. 2017;19:1192–201.
-
- Kario K, Tomitani N, Buranakitjaroen P, Chia YC, Park S, Chen CH, et al. Home blood pressure control status in 2017-2018 for hypertension specialist centers in Asia: Results of the Asia BP@Home study. J Clin Hypertens. 2018;20:1686–95.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
